ICD-10 D05.02
Billable / SpecificLobular carcinoma in situ of left breast
About ICD-10-CM D05.02
ICD-10-CM code D05.02 represents Lobular carcinoma in situ of left breast. This is a billable/specific code in the Neoplasms chapter (block D05). The 2026 edition of ICD-10-CM D05.02 became effective on October 1, 2025.
Medicare LCD Coverage for D05.02
Local Coverage Determinations (LCDs) from CMS MACs that list D05.02 as a covered diagnosis.
Showing top 10 of 1,266 total . Click a CPT for full coverage scope.
Commercial Payer Coverage
Coverage policies from major commercial payers referencing D05.02.
5 Medicare
CPT Codes Commonly Billed with D05.02
Procedures frequently paired with this diagnosis based on PayerReady's Dx↔Px linkage data.
- 81520 CMS LCD: Billing and Coding: MolDX: Breast Cancer Assay: Prosigna� CMS LCD
- Q5158 CMS LCD: Billing and Coding: Denosumab (Prolia�, Xgeva�, Jubbonti�, Wyost�, Ospomyv�,Xbryk�,Bomyntra�, Conexxence�, Stoboclo�, Osenvelt�,Bildyos�, Bilprevda�) CMS LCD
- Q5157 CMS LCD: Billing and Coding: Denosumab (Prolia�, Xgeva�, Jubbonti�, Wyost�, Ospomyv�,Xbryk�,Bomyntra�, Conexxence�, Stoboclo�, Osenvelt�,Bildyos�, Bilprevda�) CMS LCD
- Q5136 CMS LCD: Billing and Coding: Denosumab (Prolia�, Xgeva�, Jubbonti�, Wyost�, Ospomyv�,Xbryk�,Bomyntra�, Conexxence�, Stoboclo�, Osenvelt�,Bildyos�, Bilprevda�) CMS LCD
- J0897 CMS LCD: Billing and Coding: Denosumab (Prolia�, Xgeva�, Jubbonti�, Wyost�, Ospomyv�,Xbryk�,Bomyntra�, Conexxence�, Stoboclo�, Osenvelt�,Bildyos�, Bilprevda�) CMS LCD
- Q5159 CMS LCD: Billing and Coding: Denosumab (Prolia�, Xgeva�, Jubbonti�, Wyost�, Ospomyv�,Xbryk�,Bomyntra�, Conexxence�, Stoboclo�, Osenvelt�,Bildyos�, Bilprevda�) CMS LCD
Convert D05.02 to ICD-9-CM
Per CMS General Equivalence Mappings (GEMs), useful for legacy data review and historical claim analysis.
| ICD-10 | ICD-9 | Mapping Flags |
|---|---|---|
| D05.02 | 2330 | 10000 |
Flags format (5 digits): Approximate · No Map · Combination · Scenario · Choice List. Source: CMS 2017 GEMs (final version).
Codes Adjacent To D05.02
Other codes in section D00-D09 (In situ neoplasms).
ICD-10 D05.02, Billing FAQ
Is ICD-10 code D05.02 billable? +
Yes, D05.02 is a billable ICD-10-CM code that can appear as a primary or secondary diagnosis on claims.
What CPT codes are commonly billed with D05.02? +
Procedures frequently paired with D05.02 include: 81520, Q5158, Q5157, Q5136, J0897.
What ICD-9 codes does D05.02 map to? +
Per CMS GEMs, D05.02 maps to ICD-9 codes: 2330. Useful for legacy data review and historical claim analysis.
Get the full PayerReady toolkit
Free access to CPT/ICD-10 lookup, denial appeals, fee comparator, and claim auditing with credentialing enrollment.
Start free →Run this code through our claim audit tool
Check NCCI bundling, MUE limits, and modifier logic before submission.
Try the auditor →Did this page help?
Quick signal so we know what to improve.
If you want a code reference page that doesn't exist yet, email coding@payerready.com.
Tell us what's missing or wrong: coding@payerready.com. We respond within 5 business days.
Reviewed by the PayerReady Medical Coding Team
Verified against the CMS 2026 code set on May 31, 2026.
Powered by 11K CPT · 98K ICD-10 · 860K MPFS rates · 4.5M NCCI edits · 9.5M NPIs. Our data methodology · About our coding team